Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Change in Cash of $7.4 million in Q1 2026, up 166.94% on a QoQ basis from -$11.0 million in Q4 2025, and up 2700.0% year-over-year from $263000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Change in Cash across 17 years of filings, most recently posting $7.4 million for Q1 2026.
- Quarterly Change in Cash rose 2700.0% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 128.62% YoY) and the FY2025 annual result came in at $8.2 million, up 389.62% from the prior year.
- Change in Cash advanced to $7.4 million in Q1 2026, from -$11.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $50.8 million in Q1 2024 and troughed at -$51.6 million in Q2 2024.
- A 5-year average of -$868176.5 and a median of -$5.2 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash plunged 703.51% — and 2026, when it soared 2700.0%.
- Tracing ACHV's Change in Cash over 5 years: stood at $6.6 million in 2022, then plunged by 166.52% to -$4.4 million in 2023, then soared by 173.38% to $3.2 million in 2024, then slumped by 442.82% to -$11.0 million in 2025, then jumped by 166.94% to $7.4 million in 2026.
- Business Quant data shows ACHV's Change in Cash at $7.4 million in Q1 2026, -$11.0 million in Q4 2025, and -$19.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -45.97 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | 7.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.36 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -19.94 Mn |
| Jun 30, 2025 | 38.86 Mn |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | -51.64 Mn |
| Mar 31, 2024 | 50.82 Mn |
| Dec 31, 2023 | -4.37 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Jun 30, 2023 | 8.56 Mn |
| Mar 31, 2023 | -8.26 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | -11.18 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.69 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | -8.69 Mn |
| Jun 30, 2021 | 12.36 Mn |